Drug Development

Articles

The antisense drug will be the first in the companies’ joint development deal for medications to treat autoimmune disorders of the gastrointestinal tract.

Ionis Pharmaceuticals Licenses Oral RNA-based Therapeutic to Janssen

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

CPhI Pharma Awards seek nominations for excellence in development and manufacturing.

Recognizing Pharma Industry Excellence

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Recent chiral advances demonstrate promise for API synthesis.

Expanding the Chiral Toolbox

The Pharmacopoeial Discussion Group approved monographs and plans to harmonize several others.

Pharmacopeias Continue Harmonization Program

Hovione expands drug substance and HPAPI capacity in East Windsor, New Jersey.

Hovione Breaks Ground on API Facility in New Jersey

Effective harvesting and purification processes play an essential role in ensuring that biopharmaceutical manufacturing processes provide biologic drug substances with uniform and consistent properties.

Ensuring Biologic API Uniformity

The collaboration will provide GMP manufacturing ahead of future clinical studies.

CMC Biologics Will Manufacture F-star mAb² Bispecific Antibodies

A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers.

Fujifilm Diosynth Announces Collaboration With MSD on Large-Scale Biologics Facility

Process analytical technology paved the way for continuous manufacturing.

PAT: “Gateway Drug” to the 21st Century for the Pharma Industry

Application of flow chemistry for small-molecule API synthesis continues to expand thanks to research efforts.

APIs and Excipients